EDAN Diagnostics, Inc.
Country not established FDA establishment FEI 3009499478
- Devices
- 0
- Registrations
- FDA
- FDA recalls
- 1816 ongoing
Company details
- FDA FEI number
- 3009499478
- Address
- 9918 Via Pasar, San Diego, CA, 92126
FDA recalls
Recalls initiated per year
- 2017 1
- 2018 0
- 2019 0
- 2020 0
- 2021 0
- 2022 0
- 2023 0
- 2024 0
- 2025 16
- 2026 0
2025
- 24 Oct 2025 Z-1140-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1141-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1142-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1143-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1144-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1145-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1146-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1147-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1148-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1149-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1140-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Show all 18 recalls
2025
- 24 Oct 2025 Z-1150-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1151-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1152-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1153-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1154-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1155-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Full distribution text
- 24 Oct 2025 Z-1150-2026 Class II Ongoing As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
2017
- 17 Nov 2017 Z-1256-2020 Class II Terminated Firm became aware that it distributed 7 units in the U.S. that included a function that had not been cleared by U.S. FDA.
2016
- 23 Jun 2016 Z-2388-2016 Class II Terminated Incorrect CO2 readings with some patient monitors.
Full distribution text
- 23 Jun 2016 Z-2388-2016 Class II Terminated Incorrect CO2 readings with some patient monitors.